Jenifer Bear

机构：National Cancer Institute, Center for Cancer Research · ORCID：0000-0001-5065-6081

发表论文 80 篇 · 总被引 3276 次 · h-index 30

代表论文

• Efficient production and enhanced tumor delivery of engineered extracellular vesicles (2016 · Biomaterials · 被引 395)
• Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients (2021 · Cell Reports · 被引 241)
• Scalable, cGMP‐compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL‐15/lactadherin complexes (2018 · Journal of Extracellular Vesicles · 被引 180)
• Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10 (2020 · Journal for ImmunoTherapy of Cancer · 被引 155)
• Treatment with native heterodimeric IL-15 increases cytotoxic lymphocytes and reduces SHIV RNA in lymph nodes (2018 · PLoS Pathogens · 被引 80)
• SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors (2021 · European Journal of Internal Medicine · 被引 72)